Broad H3K4me3 domains: Maintaining cellular identity and their implication in super-enhancer hijacking.
Daniel KentLetizia MarchettiAneta MikulasovaLisa J RussellDaniel RicoPublished in: BioEssays : news and reviews in molecular, cellular and developmental biology (2023)
The human and mouse genomes are complex from a genomic standpoint. Each cell has the same genomic sequence, yet a wide array of cell types exists due to the presence of a plethora of regulatory elements in the non-coding genome. Recent advances in epigenomic profiling have uncovered non-coding gene proximal promoters and distal enhancers of transcription genome-wide. Extension of promoter-associated H3K4me3 histone mark across the gene body, known as a broad H3K4me3 domain (H3K4me3-BD), is a signature of constitutive expression of cell-type-specific regulation and of tumour suppressor genes in healthy cells. Recently, it has been discovered that the presence of H3K4me3-BDs over oncogenes is a cancer-specific feature associated with their dysregulated gene expression and tumourigenesis. Moreover, it has been shown that the hijacking of clusters of enhancers, known as super-enhancers (SE), by proto-oncogenes results in the presence of H3K4me3-BDs over the gene body. Therefore, H3K4me3-BDs and SE crosstalk in healthy and cancer cells therefore represents an important mechanism to identify future treatments for patients with SE driven cancers.
Keyphrases
- genome wide
- dna methylation
- copy number
- gene expression
- transcription factor
- genome wide identification
- single cell
- induced apoptosis
- cell therapy
- endothelial cells
- poor prognosis
- binding protein
- stem cells
- high throughput
- minimally invasive
- squamous cell carcinoma
- papillary thyroid
- current status
- cell death
- oxidative stress
- lymph node metastasis
- genome wide analysis